Robust, Long-Term Culture of Endoderm-Derived Hepatic Organoids for Disease Modeling

Soheil Akbari, Gülben Gürhan Sevinç, Nevin Ersoy, Onur Basak, Kubra Kaplan, Kenan Sevinç, Erkin Ozel, Berke Sengun, Eray Enustun, Burcu Ozcimen, Alper Bagriyanik, Nur Arslan, Tamer Tevfik Önder*, Esra Erdal

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

1 Citation (Scopus)
27 Downloads (Pure)

Abstract

Organoid technologies have become a powerful emerging tool to model liver diseases, for drug screening, and for personalized treatments. These applications are, however, limited in their capacity to generate functional hepatocytes in a reproducible and efficient manner. Here, we generated and characterized the hepatic organoid (eHEPO) culture system using human induced pluripotent stem cell (iPSC)-derived EpCAM-positive endodermal cells as an intermediate. eHEPOs can be produced within 2 weeks and expanded long term (>16 months) without any loss of differentiation capacity to mature hepatocytes. Starting from patient-specific iPSCs, we modeled citrullinemia type 1, a urea cycle disorder caused by mutations in the argininosuccinate synthetase (ASS1) enzyme. The disease-related ammonia accumulation phenotype in eHEPOs could be reversed by the overexpression of the wild-type ASS1 gene, which also indicated that this model is amenable to genetic manipulation. Thus, eHEPOs are excellent unlimited cell sources to generate functional hepatic organoids in a fast and efficient manner.

Original languageEnglish
Pages (from-to)627-641
Number of pages15
JournalStem Cell Reports
Volume13
Issue number4
DOIs
Publication statusPublished - 8 Oct 2019

Keywords

  • 3D organoid
  • citrullinemia
  • disease modelling
  • EpCAM
  • hepatocyte
  • hepatocyte differentiation
  • iPSC
  • liver

Fingerprint

Dive into the research topics of 'Robust, Long-Term Culture of Endoderm-Derived Hepatic Organoids for Disease Modeling'. Together they form a unique fingerprint.

Cite this